The phosphatidylinositol 3' –kinase (PI3K)-Akt signaling pathway is an intracellular signaling pathway important in regulating the cell cycle and is activated by many types of cellular stimuli or toxic insults.
It regulates fundamental cellular functions such as transcription, translation, proliferation, growth, and survival in response to extracellular signals. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates.
As shown in following picture, activation of growth factor receptor protein tyrosine kinases including epidermal growth factor receptor (EGFR) by external growth factors results in auto-phosphorylation on tyrosine residues and subsequent events to activate these intracellular pathways.
PI3K is recruited to the membrane by directly binding to phosphotyrosine consensus residues of growth factor receptors or adaptors through one or both SH2 domains in the adaptor subunit. This leads to allosteric activation of the catalytic subunit. Activation results in production of the second messenger phosphatidylinositol-3, 4, 5-trisphosphate (PIP3).
The lipid product of PI3K, PIP3, recruits a subset of signaling proteins with pleckstrin homology (PH) domains to the membrane, including PDK1 and Akt. PTEN, is a PI-3, 4, 5-P3 phosphatase, which negatively regulates the PI3K/Akt pathway.
Once activated, Akt mediates the activation and inhibition of several targets, resulting in cellular survival, growth and proliferation through various mechanisms.
In the mechanism of PI3K-Akt signaling pathway, the key molecules involved in this signaling pathway are receptor tyrosine kinase (RTKs), phosphatidylinositol 3-kinase (PI3K), phosphatidylinositol-4,5-bisphosphate (PIP2), phosphatidylinositol-3,4,5-bisphosphate (PIP3) and AKT/protein kinase B. You can click the link below to view more introduction of the two critical molecules https://www.cusabio.com/c-20715.html.
This article was written by a sweet guy from CUSABIO named PI3K-Akt Signaling Pathway and Cancer, including its history, mechanism and related diseases.
|ERBB2||ERBB2 Antibody||ERBB2 Protein||ERBB2 cDNA||ERBB2 ELISA Kit|
|ERBB3||ERBB3 Antibody||ERBB3 Protein||ERBB3 cDNA||ERBB3 ELISA Kit|
|ERBB4||ERBB4 Antibody||ERBB4 Protein||ERBB4 cDNA||ERBB4 ELISA Kit|
|EREG||EREG Antibody||EREG Protein||EREG cDNA||EREG ELISA Kit|
|F2R||F2R Antibody||F2R Protein||F2R cDNA||F2R ELISA Kit|
|FASLG||FASLG Antibody||FASLG Protein||FASLG cDNA||FASLG ELISA Kit|
|FGF1||FGF1 Antibody||FGF1 Protein||FGF1 cDNA||FGF1 ELISA Kit|
|FGF10||FGF10 Antibody||FGF10 Protein||FGF10 cDNA||FGF10 ELISA Kit|
|FGF16||FGF16 Antibody||FGF16 Protein||FGF16 cDNA||FGF16 ELISA Kit|
|FGF17||FGF17 Antibody||FGF17 Protein||FGF17 cDNA||FGF17 ELISA Kit|
|FGF18||FGF18 Antibody||FGF18 Protein||FGF18 cDNA||FGF18 ELISA Kit|
|FGF19||FGF19 Antibody||FGF19 Protein||FGF19 cDNA||FGF19 ELISA Kit|
|FGF2||FGF2 Antibody||FGF2 Protein||FGF2 cDNA||FGF2 ELISA Kit|
|FGF20||FGF20 Antibody||FGF20 Protein||FGF20 cDNA||FGF20 ELISA Kit|
|FGF21||FGF21 Antibody||FGF21 Protein||FGF21 cDNA||FGF21 ELISA Kit|
|FGF22||FGF22 Antibody||FGF22 Protein||FGF22 cDNA||FGF22 ELISA Kit|
|FGF23||FGF23 Antibody||FGF23 Protein||FGF23 cDNA||FGF23 ELISA Kit|
|FGF3||FGF3 Antibody||FGF3 Protein||FGF3 cDNA||FGF3 ELISA Kit|
|FGF4||FGF4 Antibody||FGF4 Protein||FGF4 cDNA||FGF4 ELISA Kit|
|FGF5||FGF5 Antibody||FGF5 Protein||FGF5 cDNA||FGF5 ELISA Kit|